| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |